← Evidence map

TrialBMJ open diabetes research & care2023

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering.

David M Charytan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37311602